Volasertib suppresses tumor growth and potentiates the activity of cisplatin in cervical cancer

Volasertib (BI 6727), a highly selective and potent inhibitor of PLK1, has shown broad antitumor activities in the preclinical and clinical studies for the treatment of several types of cancers. However, the anticancer effect of volasertib on cervical cancer cells is still unknown. In the present st...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Cancer Res
Main Authors: Xie, Feng-Feng, Pan, Shi-Shi, Ou, Rong-Ying, Zheng, Zhen-Zhen, Huang, Xiao-Xiu, Jian, Meng-Ting, Qiu, Jian-Ge, Zhang, Wen-Ji, Jiang, Qi-Wei, Yang, Yang, Li, Wen-Feng, Shi, Zhi, Yan, Xiao-Jian
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4731630/
https://ncbi.nlm.nih.gov/pubmed/26885445
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados